Chou Associates Management - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Chou Associates Management ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$38,323,000
+46.0%
1,648,9920.0%14.52%
+31.2%
Q1 2018$26,252,000
+747.9%
1,648,992
+1006.8%
11.07%
+735.9%
Q4 2017$3,096,000
-92.9%
148,992
-95.1%
1.32%
-91.3%
Q3 2017$43,762,000
-17.5%
3,053,8430.0%15.29%
-6.6%
Q2 2017$53,030,000
+104.3%
3,053,843
+29.7%
16.38%
+90.1%
Q1 2017$25,963,000
-8.8%
2,353,843
+20.0%
8.61%
-5.4%
Q4 2016$28,471,000
-19.8%
1,960,843
+35.5%
9.10%
-30.7%
Q3 2016$35,520,000
+21.9%
1,446,8430.0%13.14%
+18.2%
Q2 2016$29,139,000
+13.3%
1,446,843
+48.1%
11.12%
+33.2%
Q1 2016$25,725,000976,8438.35%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders